by Grow Up Conference | Apr 18, 2024 | Canadian Evergreen, Media Partners
This post is presented by our media partner Canadian Evergeen
View the original article here.
You can get drunk at Bavaria’s world-famous Oktoberfest, but don’t get high.
The southern German state will ban smoking cannabis at public festivals, inside beer gardens, and even at the Oktoberfest, the world’s most popular beer festival, the state’s government announced Tuesday.
Local authorities in Bavaria will also be allowed to prohibit cannabis consumption in public areas such as outdoor swimming pools and leisure parks such as Munich’s Englischer Garten, German news agency dpa reported.
“Our aim is to limit cannabis consumption in public spaces,” said Bavarian Health Minister Judith Gerlach. “That is important for health protection and especially for protecting children and young people.”
Bavaria’s move comes after Germany legalized possession of small amounts of cannabis for recreational use all over the country at the beginning of this month.
READ MORE: Germany has legalized possession of small amounts of cannabis. Not everyone is mellow about that.
Bavaria’s conservative-led state government has been particularly vocal in its opposition to the partial legalization of cannabis.
Germany’s nationwide new rules went into force on April 1, legalizing possession by adults of up to 25 grams (nearly 1 ounce) of marijuana for recreational purposes and allowing individuals to grow up to three plants for their personal use.
A second part of the legislation, under which German residents age 18 and older will be allowed to join nonprofit cannabis-growing clubs from which they can buy marijuana, takes effect July 1.
READ MORE: Austria steps up police checks in border areas after Germany liberalizes cannabis rules
In its strict interpretation of the cannabis law, Bavaria’s state government also wants to ban smoking cannabis in designated smoking rooms and smoking areas such as the outdoor areas in restaurants and cafes.
The ban will also extend to the heating and vaporization of cannabis and cannabis products, dpa reported.
Bavaria’s state government argues that the ban of weed consumption at public festivals including the Oktoberfest is needed because consumers are not allowed to smoke cannabis near minors, and children and young people are regularly present there.
To get the week’s latest must-read stories from the cannabis world direct to your inbox, sign up for our weekly newsletter at canadianevergreen.com. You can also follow us on Facebook, Instagram and Twitter.
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Media Partners, Stratcann
This post is presented by our media partner Stratcann
View the original article here.
As part of its work looking into issues around the federal government’s ArriveCAN app, the House of Commons Standing Committee on Public Accounts (PACP) recently heard from Aurora Cannabis Chief Information Officer Darryl Vleeming,
Vleeming spoke with the committee in his current role as vice president and chief information officer at Canada Border Services Agencies (CBSA).
The committee questioned Vleeming on the issue of GC Strategies, a company which received millions of dollars from the federal government to develop the mobile app provided by the Canada Border Services Agency in 2020, while Vleeming was still with Aurora.
Vleeming was speaking to the committee along with Jonathan Moor, vice-president, comptrollership branch of the CBSA, and from the Office of the Auditor General: Andrew Hayes, deputy auditor general; Sami Hannoush, principal; and Lucie Després, director.
During questioning, Bloc Québécois MP Nathalie Sinclair-Desgagné questioned Vleeming about a hack that occurred when he was chief information officer at Aurora Cannabis on Christmas in 2020.
In that breach of security, hackers stole all of Aurora’s computer data, noted Sinclair-Desgagné, including copies of driver’s licences “and other highly confidential documents.”
When the hackers tried to sell that data in an online marketplace, she noted, they used a copy of Vleeming’s passport as evidence that their claims were real.
Vleeming confirmed the hackers had indeed shared his passport but said Aurora’s security system had limited them to accessing only “a very small amount of data.”
“The data breach actually got a very small amount of data from Aurora, and we were subjected to blackmail,” Vleeming told the committee. “Basically, they tried to force us to pay to not release it, but the amount of information they stole was extremely limited, so we made a decision as an organization not to pay.”
Sinclair-Desgagné questioned whether this showed a lapse in his duties as chief information officer at the time, but Vleeming says such hacks are “never ideal” but common.
“You’re never as prepared as you could be, but the reality is that cyber-attacks continue to increase worldwide,” he said as part of his final comments on the matter. “You just have to google the number of companies that get hacked on a daily basis. It is expected. What you have to do is limit the damage, and in this case the damage was extremely minimal.”
The hackers that stole data from Aurora Cannabis posted 11 sample images on January 7, 2021, as “proof of concept.” In addition to Vleeming’s passport, it appeared to include an Alberta driver’s licence belonging to Amy Lamoureux, a supply chain manager at the company.
Aurora maintains that no patient data from its medical cannabis program had been compromised.
Related Articles
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis News Wire, Media Partners
In a fresh lawsuit brought against the U.S. Department of Justice (DOJ) and the U.S. Drug Enforcement Administration (DEA), MMJ BioPharma Cultivation, a marijuana company based in Rhode Island, is seeking to halt an administrative law judge’s review of its application to produce cannabis for research.
The lawsuit contends that DEA director Anne Milgram unlawfully appointed administrative law Judge Teresa Wallbaum. The company argues that this action violates the constitutionality of the process and the decision-maker involved, as well as lacks accountability to the president. The lawsuit names DEA Administrator Anne Milgram, DEA Administrative Law Judge Teresa Wallbaum, the DOJ and U.S. Attorney General Merrick Garland as defendants.
The company submitted its application to legally cultivate cannabis for research in 2018 to create clinical trials medicines addressing conditions such as Huntington’s disease and multiple sclerosis. However, it claims that despite applying five years ago, it has faced delays and uncertainties from the DEA leading to significant negative impacts on its operations, including the inability to expand its workforce and the loss of revenue.
Despite the legal action, Wallbaum stated that given the available facts and unique circumstances, a stay seemed appropriate. Highlighting MMJ’s challenge to the tribunal’s jurisdiction under Axon, which allows federal courts to handle structural challenges, she indicated that this presents a complex issue affecting the DEA’s possibility of success. Moreover, she referred to the Axon court’s decision, underscoring that exposing a party to legal proceedings carried out within an unconstitutional framework could itself amount to legal harm.
During recent committee hearings in Congress, Congressman Earl Blumenauer raised concerns about medical marijuana research and treatment delays. He noted that delays such as MMJ’s had an impact on Biden’s administration.
The company’s president, Duane Boise, condemned the DEA’s action, accusing the agency of impeding cannabis research. He underlined that even while MMJ complies with the law, the DEA has not, which has resulted in hardship for patients in need as a result of inaction on the part of the government.
Attorney Tim Moynahan, who is also the company’s chair, expressed hope that by challenging the DEA’s constitutionality while offering a path for correction, this case would be resolved. He urged the DEA to settle the matter, especially considering MMJ’s crucial role in developing drugs to aid patients with conditions such as Huntington’s disease and multiple sclerosis.
The scheduled hearing before the DEA administrative law judge on April 10, 2024, has been temporarily halted following the filing of the federal lawsuit.
For quite some time, complaints have persisted about the way the DEA handles applications related to marijuana research. The outcome of this lawsuit could play a role in bringing about some needed changes so that companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) can face fewer hurdles should they ever require DEA approval for any cannabis study that they wish to undertake.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis Prospect Magazine, Media Partners
This post is presented by our media partner Cannabis Prospect Magazine
View the original article here.
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis Prospect Magazine, Media Partners
This post is presented by our media partner Cannabis Prospect Magazine
View the original article here.
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis Prospect Magazine, Media Partners
This post is presented by our media partner Cannabis Prospect Magazine
View the original article here.
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis Prospect Magazine, Media Partners
This post is presented by our media partner Cannabis Prospect Magazine
View the original article here.
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Grow Opportunity, Media Partners
(Globe Newswire) Vancouver — Village Farms International, Inc. notes its disappointment that a change to the current Cannabis Excise Duty was not included in today’s Canadian federal budget.
“We remain focused on working with industry and government to create more favourable tax conditions for the cannabisindustry and advance a level playing field for all,” said Michael DeGiglio, president and CEO, Village Farms. “While Village Farms’ Canadian Cannabis division remains profitable under the current taxation framework, it is our view that the true measure of success for any industry is the ability to contribute tax revenue from profitable income, not taxation from topline sales.”
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Grow Opportunity, Media Partners
“Organigram is very disappointed that Deputy Prime Minister Freeland did not announce a review of the cannabis excise framework in Budget 2024,” said Beena Goldenberg, CEO of Organigram Inc., a federally licensed producer of cannabis products with facilities in Moncton, Lac-Supérieur and Winnipeg.
Goldenberg noted that, “Canada’s federally licensed cannabis producers struggle to compete with aggressive illicit suppliers, who continue to operate with relative impunity and who are not subject to any regulatory regime.” She also noted that “the House of Commons Standing Committee on Finance and Health Canada’s Expert Panel on the Legislative Review of the Cannabis Act both recognized these pressures and recommended that Finance Canada rework the excise framework. We simply don’t understand why the federal government ignored these recommendations.”
“The Federal Government has ignored the needs of the sector and jeopardized its ability to compete with illicit suppliers,” explained Goldenberg, adding, “Lowering the excise rate so that it is limited to a 10 per cent ad valorem rate and amending the onerous excise stamping requirements will free up much needed capital to allow Canada’s nascent cannabis sector to deliver on the public policy objectives of cannabis legalization to keep profits out of the hands of criminals, and to keep kids safe.”
This post was originally published by our media partner here.
by Grow Up Conference | Apr 17, 2024 | Cannabis News Wire, Media Partners
The possession and use of cannabis is illegal under federal law in the United States. Despite this, many states across the country have legalized the drug for recreational or medical purposes. This comes as public support for legalization continued to increase.
Below are some facts about cannabis in the United States, based on recent data.
Almost 90% of Americans want cannabis to be legalized for recreational or medical use.
A survey conducted by Pew Research Center in January found that 88% of adults in America think cannabis should be legal for recreational or medical use.
More than 50% live in a state where both recreational and medical use is legal.
A data analysis conducted by the Census Bureau found that 54% of Americans live in legal states, while another 74% live in states where cannabis is legal for either medical or recreational use.
The first states to legalize recreational cannabis were Washington and Colorado.
Almost 80% of Americans live in a county with at least one marijuana dispensary.
According to the Census Bureau analysis, there are almost 15,000 marijuana dispensaries across the country. More than 75% of individuals live in states where recreational marijuana is legal while another 23% live in medical states.
The states with the largest number of dispensaries include Oklahoma, California, Michigan, Colorado and Florida.
Support for cannabis legalization has grown greatly over the last 20 years.
A 2023 Gallup survey found that 70% of adults support the legalization of cannabis. This is more than double the number of individuals who supported the drug’s legalization in 2000.
Views on cannabis legalization differ by political party, age, ethnicity and race.
An estimated 71% of adults aged 30 years and younger are in favor of recreational and medical legalization of cannabis. In comparison, 31% of those aged 75 and older support cannabis legalization for recreational and medical use. In addition, 72% of Democrats favor cannabis legalization for both uses while 42% of GOP members favor the drug’s legalization for both uses.
The January survey also found that 65% of Blacks, 59% of Whites and 45% of Asian Americans and Hispanics support the drug’s legalization for recreational and medical use.
About 50% of Americans have used cannabis.
A survey carried out by the National Survey on Drug Use and Health last year found that 50% of Americans have used cannabis before. This is a smaller share than the 64% who have used tobacco products and the 84% who admitted to consuming alcohol.
All these statistics and facts point to the changing perception of marijuana, and enterprises such as SNDL Inc. (NASDAQ: SNDL) are looking forward to the time when the federal prohibition of cannabis finally ends.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
